These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 33796864)
1. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. Oshima K; Zhao J; Pérez-Durán P; Brown JA; Patiño-Galindo JA; Chu T; Quinn A; Gunning T; Belver L; Ambesi-Impiombato A; Tosello V; Wang Z; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Balbin M; Nicolas C; Gastier-Foster JM; Devidas M; Loh ML; Paietta E; Tallman MS; Rowe JM; Litzow M; Minden MD; Meijerink J; Rabadan R; Ferrando A Nat Cancer; 2020 Nov; 1(11):1113-1127. PubMed ID: 33796864 [TBL] [Abstract][Full Text] [Related]
2. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Oshima K; Khiabanian H; da Silva-Almeida AC; Tzoneva G; Abate F; Ambesi-Impiombato A; Sanchez-Martin M; Carpenter Z; Penson A; Perez-Garcia A; Eckert C; Nicolas C; Balbin M; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Devidas M; Loh ML; Kirschner-Schwabe R; Palomero T; Rabadan R; Ferrando AA Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11306-11311. PubMed ID: 27655895 [TBL] [Abstract][Full Text] [Related]
3. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment. Demosthenous C; Lalayanni C; Iskas M; Douka V; Pastelli N; Anagnostopoulos A Curr Probl Cancer; 2019 Jun; 43(3):222-227. PubMed ID: 29895435 [TBL] [Abstract][Full Text] [Related]
4. The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions. Bhatla T; Jones CL; Meyer JA; Vitanza NA; Raetz EA; Carroll WL J Pediatr Hematol Oncol; 2014 Aug; 36(6):413-8. PubMed ID: 24942023 [TBL] [Abstract][Full Text] [Related]
5. Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib. August KJ; Guest EM; Lewing K; Hays JA; Gamis AS Pediatr Blood Cancer; 2020 Mar; 67(3):e28062. PubMed ID: 31724803 [TBL] [Abstract][Full Text] [Related]
6. How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Frey NV; Luger SM Blood; 2015 Jul; 126(5):589-96. PubMed ID: 25966988 [TBL] [Abstract][Full Text] [Related]
7. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications. Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993 [TBL] [Abstract][Full Text] [Related]
8. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses. Szczepanek J; Styczyński J; Haus O; Tretyn A; Wysocki M Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):61-8. PubMed ID: 21246408 [TBL] [Abstract][Full Text] [Related]
9. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults. Ronson A; Tvito A; Rowe JM Curr Oncol Rep; 2016 Jun; 18(6):39. PubMed ID: 27207612 [TBL] [Abstract][Full Text] [Related]